109 related articles for article (PubMed ID: 2646133)
1. Current status of chemotherapy for gastric cancer.
Wils J; Bleiberg H
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):3-8. PubMed ID: 2646133
[TBL] [Abstract][Full Text] [Related]
2. [A current overview of chemotherapy in advanced gastric cancer].
Ogawa M
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2161-8. PubMed ID: 2660747
[TBL] [Abstract][Full Text] [Related]
3. FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Kelsen D; Atiq OT; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
J Clin Oncol; 1992 Apr; 10(4):541-8. PubMed ID: 1548519
[TBL] [Abstract][Full Text] [Related]
4. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
[TBL] [Abstract][Full Text] [Related]
5. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
[TBL] [Abstract][Full Text] [Related]
6. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.
Wils J; Bleiberg H; Dalesio O; Blijham G; Mulder N; Planting A; Splinter T; Duez N
J Clin Oncol; 1986 Dec; 4(12):1799-803. PubMed ID: 3783204
[TBL] [Abstract][Full Text] [Related]
7. Perspectives in chemotherapy of advanced gastric cancer.
Wils JA
Anticancer Drugs; 1991 Apr; 2(2):133-7. PubMed ID: 1835661
[TBL] [Abstract][Full Text] [Related]
8. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
Wils JA; Klein HO; Wagener DJ; Bleiberg H; Reis H; Korsten F; Conroy T; Fickers M; Leyvraz S; Buyse M
J Clin Oncol; 1991 May; 9(5):827-31. PubMed ID: 2016625
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of advanced gastric carcinoma.
Queisser W; Flechtner H
Onkologie; 1986 Dec; 9(6):319-31. PubMed ID: 3547223
[TBL] [Abstract][Full Text] [Related]
10. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S;
J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of advanced gastric cancer: present status, future prospects.
Macdonald JS; Gohmann JJ
Semin Oncol; 1988 Jun; 15(3 Suppl 4):42-9. PubMed ID: 3293218
[TBL] [Abstract][Full Text] [Related]
13. Current status of chemotherapy for advanced gastric cancer.
Wils JA
Anticancer Res; 1987; 7(4B):755-9. PubMed ID: 3314675
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.
Waters JS; Norman A; Cunningham D; Scarffe JH; Webb A; Harper P; Joffe JK; Mackean M; Mansi J; Leahy M; Hill A; Oates J; Rao S; Nicolson M; Hickish T
Br J Cancer; 1999 Apr; 80(1-2):269-72. PubMed ID: 10390007
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.
Tsavaris N; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekas D; Tsetis A; Klonaris C
Chemotherapy; 1996; 42(3):220-6. PubMed ID: 8983891
[TBL] [Abstract][Full Text] [Related]
16. The treatment of advanced gastric cancer.
Wils J
Semin Oncol; 1996 Jun; 23(3):397-406. PubMed ID: 8658224
[TBL] [Abstract][Full Text] [Related]
17. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
18. CPT-11 in gastrointestinal cancer.
Bleiberg H
Eur J Cancer; 1999 Mar; 35(3):371-9. PubMed ID: 10448285
[TBL] [Abstract][Full Text] [Related]
19. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
Ohtsu A; Yoshida S; Miyata Y; Shimada Y
Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
